Thatcher Heumann is an Oncology physician affiliated with Bloomberg. OpenAlex indexes 51 publications with 677 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372320013
Telephone
615-936-2000Provider last certified this registry record 20 Jun 2025.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eisai Inc.Program year20237 payments
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
49.1%Opioid Agonist22.4%Oxycodone Hcl100%Part D≥15 patientsPhenothiazine15.5%Prochlorperazine Maleate100%Part D≥13 patients+ 1 more class in this area
Metabolism & gastrointestinal
24.1%Serotonin-3 Receptor Antagonist24.1%Ondansetron Hcl61%Ondansetron Odt39%Part D<11 patientsBlood & clotting
15.5%Factor Xa inhibitor15.5%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Nature Communications
2026 - Multiomic analysis and oncologic outcomes in pancreatic cancer by PIN1 expression.
Journal of Clinical Oncology
2026 - The presenting symptoms of patients with appendiceal malignant tumors.
Journal of Clinical Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Arturo Casadevall, MD
Bloomberg
Elizabeth Jaffee, MD
Bloomberg
Daniel Laheru, MD
Bloomberg
William Sharfman, MD
Bloomberg
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”